Ex vivo-model design and evaluation of the sensitivity of blast cells to chemotherapy as a way to personalize the treatment of acute myeloid leukemia

Ex vivo-model design and evaluation of the sensitivity of blast cells to chemotherapy as a way to personalize the treatment of acute myeloid leukemia

Despite continuous attempts to improve therapy, the outcomes of acute myeloid leukemia remain almost unchanged over last decades. Drugs made with a more complete understanding of the biology of acute myeloid leukemia do not equal the hopes for better prognosis. The best results are achieved only wit...

Full description

Bibliographic Details
Main Authors: A. S. Polyakov, Ya. A. Noskov, Yu. V. Nikitin, V. V. Tyrenko, S. N. Kolubaeva, A. N. Bogdanov, V. N. Semelev, O. R. Petrova, S. V. Bondarchuk, D. K. Zhogolev, A. D. Zolotarev, A. V. Kovalev, Yu. E. Puchkova
Format: Article
Language:Russian
Published: ABV-press 2019-07-01
Series:Onkogematologiâ
Subjects:
acute myeloid leukemia
secondary acute myeloid leukemia
ex vivo model
drug sensitivity testing
genotoxicity
micronucleus test
fluorescence activated cell sorting
individualization of drug therapy
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/349

Internet

https://oncohematology.abvpress.ru/ongm/article/view/349

Similar Items